| Item |
Information |
|
Drug Groups
|
approved |
|
Description
|
A theophylline derivative with broncho- and vasodilator properties. It is used in the treatment of asthma, cardiac dyspnea, and bronchitis. [PubChem] |
| Indication |
For relief of acute bronchial asthma and for reversible bronchospasm associated with chronic bronchitis and emphysema. |
| Pharmacology |
Dyphylline, a xanthine derivative, is a bronchodilator used for relief of acute bronchial asthma and for reversible bronchospasm associated with chronic bronchitis and emphysema. Dyphylline is a xanthine derivative with pharmacologic actions similar to theophylline and other members of this class of drugs. Its primary action is that of bronchodilation, but it also exhibits peripheral vasodilatory and other smooth muscle relaxant activity to a lesser degree. |
| Toxicity |
LD50=1954 mg/kg (orally in mice) |
| Affected Organisms |
| • |
Humans and other mammals |
|
| Biotransformation |
Hepatic |
| Half Life |
2 hours (range 1.8 - 2.1 hours) |
| Protein Binding |
84% |
| Elimination |
Dyphylline exerts its bronchodilatory effects directly and, unlike the-ophylline, is excreted unchanged by the kidneys without being metabolized by the liver. Approximately 88% of a single oral dose can be recovered from the urine unchanged. |
| External Links |
|